Latest stories on IDYA
IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs | IDYA Stock News
StockTitan56 · neutralproduct/pr
IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs
PR Newswire63 · neutralproduct/pr
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | IDYA Stock News
StockTitan50 · neutralgeneral
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PR Newswire50 · neutralgeneral
IDEAYA Biosciences, Inc. (IDYA) files 8-K
SEC 8-K50 · neutralgeneral
Ideaya Advances IDE034 Into First-in-Human Trial for Advanced Solid Tumors
TipRanks63 · neutralproduct/pr
IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors
PR Newswire50 · neutralgeneral
IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors | IDYA Stock News
StockTitan50 · neutralgeneral
Ideaya Biosciences: 'Strong Buy' On Darovasertib NDA Filing Submission Completion In H2 2026
Seeking Alpha73 · bullishanalyst
IDEAYA Biosciences Raises $324 Million in Equity Offering
TipRanks24 · bearishgeneral
IDEAYA Biosciences, Inc. (IDYA) files 8-K
SEC 8-K50 · neutralgeneral
IDYA Raises $300 Million in Oversized Stock and Pre-Funded Warrant Offering—What Does This Signal for the Company’s Growth Path?
MarketChameleon24 · bearishgeneral
IDEAYA Biosciences prices $300M public offering of shares and pre-funded warrants at $27/share
Seeking Alpha24 · bearishgeneral
IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants
PR Newswire24 · bearishgeneral
IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants | IDYA Stock News
StockTitan24 · bearishgeneral
IDEAYA files shelf offering to raise up to $300M
Seeking Alpha28 · bearishgeneral
IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | IDYA Stock News
StockTitan24 · bearishgeneral
IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
PR Newswire28 · bearishgeneral
IDEAYA to work with Roche on combo pancreatic cancer treatment
Seeking Alpha63 · neutralproduct/pr
IDEAYA, Roche launch PRMT5 and pan-RAS collaboration
TipRanks63 · neutralproduct/pr
IDEAYA Biosciences Announces Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer | IDYA Stock News
StockTitan63 · neutralproduct/pr